Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran (Q83848907)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 April 2011
edit
Language Label Description Also known as
English
Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran
scientific article published on 13 April 2011

    Statements

    Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit